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Abstract 
Background 
Minimally invasive treatment of benign ureteral strictures is still challenging because of its 
technical complexity. In this context, robot-assisted surgery may overcome the limits of the 
laparoscopic approach. 
Objective 
To evaluate outcomes for robotic ureteral repair in a multi-institutional cohort of patients treated for 
ureteropelvic junction obstruction and ureteral stricture (US) at four tertiary referral centres. 
Design, setting, and participants 
This retrospective study reports data for 183 patients treated with standard robot-assisted 
pyeloplasty (PYP) and robotic uretero-ureterostomy (UUY) at four high-volume centres from 
January 2006 to September 2014. 
Surgical procedure 
Robotic PYP and robot-assisted UUY were performed according to previously reported surgical 
techniques. 
Outcome measurements and statistical analysis 
Preoperative, intraoperative, and postoperative variables and outcomes were assessed. A descriptive 
statistical analysis was performed. 
Results and limitations 
No robot-assisted UUY cases required surgical conversion, while 2.8% of PYP cases were not 
completed robotically. The median operative time was 120 and 150 min for robot-assisted PYP and 
robot-assisted UUY, respectively. No intraoperative complications were reported. The overall 
complication rate for all procedures was 11% (n = 20) and complications were mostly of low grade. 
The high-grade complication rate was 2.2% (n = 4). At median follow-up of 24 mo, the overall 
success rate was >90% for both procedures. The study limitations include its retrospective nature 
and the heterogeneity of the study population. 
Conclusions 
Robotic surgery for benign US is safe and effective, with limited risk of high-grade complications 
and good intermediate-term results. 
Patient summary 
In this study we review the use of robotic surgery at four different tertiary care centres in the 
treatment of patients affected by benign ureteral strictures. Our results demonstrate that robotic 
surgery is a safe alternative to the standard open approach in the treatment of ureteral strictures. 
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1. Introduction 
The worldwide spread of robotic surgical technology such as the da Vinci system (Intuitive 
Surgical, Sunnyvale, CA, USA) has changed the way urologists approach minimally invasive 
complex reconstructive procedures in the last 10 yr. As an example, robot-assisted radical 
prostatectomy has improved surgeon vision and facilitated difficult steps such as nerve-sparing 
dissection and urethral anastomosis [1]. 
Besides radical prostatectomy, robotic technology has been adopted for the treatment of several 
other urologic conditions such as ureteral stricture (US). Although the laparoscopic approach in this 
field has been described, its widespread adoption has been limited by technical issues. Open surgery 
is still the most frequent approach for these complex reconstructions [2]. However, robot-assisted 
surgery represents a feasible and less challenging minimally invasive alternative to open surgery. 
The main advantages of the Da Vinci system are greater dexterity for intracorporeal suturing and 
better three-dimensional visualization of the surgical field. Therefore, this technology may help 
surgeons to overcome the traditional limits of laparoscopic surgery and may be safely adopted for 
benign ureteral conditions such as ureteropelvic junction obstruction (UPJO) and US. 
Here we describe a multi-institutional cohort of patients who underwent robot-assisted ureteral 
repair for benign US at four tertiary care centres, and evaluate the feasibility and outcomes for this 
approach. 
2. Materials and methods 
2.1. Study population 
After institutional review board approval in each centre, data for 183 patients treated for UPJO and 
US from January 2006 to September 2014 at four high volume institutions (Humanitas Hospital, 
Milan, Italy; Ospedale San Raffaele, Milan, Italy; OLV Clinic, Aalst, Belgium; S. Luigi Gonzaga 
Hospital, Orbassano, Italy) were collected. 
Inclusion criteria for the study are all the patients with a UPJO or US, including cases of either 
primary or recurrent obstruction, treated with a “simple” ureteral anastomosis. Patients who had 
recent pyelonephritis or urinary tract infection were excluded. Preoperative clinical assessment of 
patients with UPJO included clinical evaluation of symptoms, mercaptoacetyltriglycine (MAG)-3 
diuretic renal scans, and computed tomography (CT) urography. The preoperative work-up for 
patients affected by US included CT urography. Patients were selected for surgery according to the 
presence of symptoms and/or evidence of obstruction on diagnostic imaging. 
Follow-up included an abdominal ultrasound, urinalysis, and a urine culture after 1 mo, as well as 
CT urography and a MAG-3 diuretic renal scan after 6 mo for patients affected by UPJO 
obstruction and US. Abdominal ultrasound was repeated at 12 mo and annually thereafter. Follow-
up visits were at 1, 3, 6, and 12 mo, and annually thereafter, with clinical evaluation of symptom 
relief at each visit. 
The study hypothesis was that robotic surgery is a feasible, safe, and effective minimally-invasive 
strategy for treatment of UPJO and US. The criteria for success for patients treated for UPJO and 
US were resolution of symptoms, no radiologic evidence of obstruction on CT urography, and no 
functional evidence of obstruction on MAG-3 renal scans. 
2.2. Surgical techniques 
In this multi-institutional study, patients were treated using one of three different robotic surgical 
techniques according to the site of the ureteral disease. Patients affected by UPJO underwent robot-
assisted pyeloplasty. Patients affected by proximal US (starting from the ureteral pelvic junction to 
the external iliac vessels) underwent robot-assisted uretero-ureterostomy. Patients affected by distal 
US (starting from the external iliac vessels to the intramural segment of the ureter) underwent 
robot-assisted ureteral reimplantation. 
Surgical techniques for robot-assisted pyeloplasty and robot-assisted uretero-ureterostomy have 
previously been described [3] and [4]. For robot-assisted ureteral reimplantation, the patient is 
positioned in the dorsal lithotomy and Trendelenburg position (20°) and the robot is brought into 
position between the patient's legs. An orogastric tube is placed before gaining access to the 
intraperitoneal space to decompress the stomach. Traditional open access is used to gain access to 
the intraperitoneal space. Port placement is illustrated in Fig. 1, with two 8-mm robotic trocars in a 
triangular arrangement in relation to the 12-mm robotic camera port at the umbilicus. Additional 5-
mm and 12-mm assistant ports are positioned ipsilateral to the defect. 
 
Fig. 1.  
Port placement. 
Figure options 
After port positioning, the colon is swept aside and its peritoneal reflections are transected at the 
line of Toldt to access the retroperitoneal cavity ipsilateral to the US site. At this point, the stenotic 
portion of the ureter is usually identified as a bulge in the ureteral wall. However, in some cases a 
ureteroscope may also used in this surgical step to identify the stenotic area, as first described by 
Glinianski et al [5]. Dissection of the ureter should be performed carefully to avoid disruption of the 
arterial blood supply. Transection of the affected portion of the ureter is completed using robotic 
scissors. Spatulation of the ureter is then performed. At this point, careful dissection of the bladder 
is completed to allow adequate mobilisation of the bladder on its pedicle. Further mobilisation can 
be achieved by freeing the bladder superiorly from the peritoneum. Periodic filling and voiding of 
the bladder through a Foley catheter are performed to determine whether sufficient mobilisation had 
been achieved to reach the transected ureter. This is important to obtain a tension-free anastomosis. 
For transperitoneal extravesical ureteral reimplantation, the bladder is directly incised at the site of 
the new ureteral orifice, which should be medial to the tendon to allow for a ureteral path that is as 
straight as possible. The bladder mucosa is then reached and two marker stitches are placed before 
incision to simplify the subsequent anastomosis. A small incision is made in the upper part of the 
isolated mucosa to access the bladder. Two running sutures with a 3-0 Vicryl SH needle are then 
used to complete the vesicoureteral anastomosis according to the modified Lich-Gregoire technique. 
The vesical muscular part is then closed over the anastomosis with a tension-free suture. The 
peritoneum is closed over the anastomosis. For patients suffering from bladder outlet obstruction, 
the Politano-Leadbetter technique is generally adopted to minimize the risk of ureterovesical reflux. 
If a tension-free ureterovescical anastomosis cannot be completed with simple bladder mobilisation, 
a psoas bladder hitch or a Boari flap may be indicated. A transbladder psoas hitch antireflux 
reimplantation has been described by De Naeyer et al [6]. If a psoas hitch still leaves the planned 
anastomosis under tension, a Boari flap may be created, as described by Schimpf et al [7]. 
After all these reconstructive procedures, a bladder catheter and suction drain were always left in 
place. In addition, a JJ stent was placed and removed approximately 1 mo after surgery. 
3. Results 
Overall, 145 patients were treated with robot-assisted pyeloplasty for UPJO, 17 patients underwent 
robotic uretero-ureterostomy for proximal US, and 21 patients underwent robotic ureteral 
reimplantation for distal US. 
3.1. Descriptive analysis 
Preoperative characteristics for the overall population are summarised in Table 1. The majority of 
patients were symptomatic (76%), and the most common symptom was flank pain (67.2%). 
Detailed patient history details are also listed in Table 1. Overall, 31 subjects (17%) had undergone 
previous ureteral surgery. Specifically, 14 patients underwent ureteroscopy (7.7%), five patients 
(2.7%) were treated with JJ stenting for hydronephrosis, one patient (0.5%) underwent open ureter 
reimplantation for a distal US, and eight (4.4%) and three (1.6%) patients were treated with open 
pyeloplasty and endopyelotomy, respectively, for UPJO. In addition, two (1.4%) patients had an 
iatrogenic US, one following removal of a retroperitoneal mass and one following a hysterectomy. 
The median follow-up was 24 mo (range 6–80). 
Table 1.  
Descriptive characteristics for the overall population and detailed patient history. 
Parameter Value 
Total patient population (n) 183 
Mean age, yr (median) [range] 43 (42) [6–80] 
Mean body mass index, kg/m
2
 (median) [range] 23 (23) [16–42] 
Gender, n (%) 
 
 Male 88 (48) 
 Female 95 (52) 
American Society of Anesthesiologists score, n (%) 
 
 1 150 (82) 
 2 27 (14.8) 
 3 6 (3.2) 
Procedure, n (%) 
 
 Robotic pyeloplasty 145 (79.2) 
 Robotic uretero-ureterostomy 17 (9.3) 
 Robotic ureteral reimplantation (%) 21 (11.5) 
Previous ureteral surgery, n (%) 31 (17) 
Symptoms, n (%) 
 
 Flank pain 123 (67.2) 
 Haematuria/other 11 (6) 
 Hyperpyrexia 5 (2.7) 
 Asymptomatic 44 (24) 
Previous urinary tract infection, n (%) 37 (20) 
Mean follow-up, mo (median) [range] 30 (24) [2–80] 
Parameter Value 
Patient history by procedure 
 
Robotic pyeloplasty, n (%) 
 
 Ureteropelvic junction obstruction 145 (100) 
Robotic uretero-ureterostomy, n (%) 
 
 Previous ureteral surgery for ureteral calculi 12 (70.6) 
 Iatrogenic US following retroperitoneal mass removal 1 (6) 
 Primary congenital stricture 4 (23.4) 
Robotic ureteral reimplantation, n (%) 
 
 Previous ureteral surgery for ureteral calculi 9 (43) 
 Iatrogenic distal US following hysterectomy 1 (4.8) 
 Primary obstructed megaureter 11 (52.2) 
US = ureteral stricture. 
Table options 
For robotic pyeloplasty, the median operative time was 120 min. The median hospital stay was 5 d 
(range 2–12 d). The median time to catheter and drainage removal was 3 d (range 2–9) and 4 d 
(range 2–10), respectively (Table 2). 
Table 2.  
Preoperative, intraoperative, and postoperative characteristics for the study population. 
 
Robotic 
pyeloplasty 
Robotic uretero-
ureterostomy 
Robotic 
reimplantation 
Preoperative data 
   
Side, n (%) 
   
 Right 73 (50.3) 11 (64.7) 11 (52.4) 
 Left 72 (49.7) 6 (35.3) 10 (47.6) 
Surgical approach, n (%) 
   
 Transperitoneal 107 (73.8) 17 (100) 21 (100) 
 Retroperitoneal 34 (23.4) 
  
 Transmesocolic 4 (2.8) 
  
Previous ureteral surgery, n 
(%) 
17 (11.7) 12 (70.6) 2 (9.5) 
Symptoms, n (%) 107 (73.8) 16 (94.1) 16 (76.2) 
 Previous urinary tract 
infection 
25 (17.2) 4 (23.5) 8 (38.0) 
 Asymptomatic 38 (26.2) 1 (5.9) 5 (23.8) 
 Renal colic/pain 96 (66.2) 16 (94.1) 11 (52.4) 
 Haematuria 3 (2.1) 
 
2 (9.5) 
 Other 8 (5.5) 
 
3 (14.3) 
Intraoperative data 
   
 Robotic 
pyeloplasty 
Robotic uretero-
ureterostomy 
Robotic 
reimplantation 
Intraoperative complications 
(n) 
0 0 0 
Surgical conversion, n (%) 4 (2.8) 0 0 
Additional trocars (n) 0 0 0 
Postoperative complications, 
n (%) 
12 (8.3) 3 (17.6) 5 (23.8) 
 Clavien-Dindo I 5 (3.4) 2 (11.7) 2 (9.5) 
 Clavien-Dindo II 5 (3.4) 1 (5.8) 1 (4.8) 
 Clavien-Dindo IIIa/IIIb 2 (1.5) 0 2 (9.5) 
 Clavien-Dindo IV 0 0 0 
Mean operative time, min 
(median) [range] 
128 (120) [60–
285] 
178 (150) [100–420] 166 (165) [90–255] 
Postoperative data 
   
Mean hospital stay, d 
(median) [range] 
4.7 (5) [2–12] 5 (5) [4–9] 8 (5) [4–30] 
Mean drain removal, d 
(median) [range] 
4 (4) [2–10] 3 (3) [3,4] 5 (3) [1–29] 
Mean catheter removal, d 
(median) [range] 
3 (3) [2–9] 2.6 (2) [2–5] 5 (4) [1–15] 
Mean pain score on discharge 
(median) [range] 
1 (1) [0–7] 1 (1) [0–3] 1 (0) [0–2] 
Table options 
The median operative time was 150 min (range 100–420) for robot-assisted uretero-ureterostomy 
and 165 min (range 90–255) for robot-assisted ureteral reimplantation, and the median hospital stay 
was 5 d (range 4–9 and 4–30, respectively). The median time to catheter and drainage removal was 
2 d (range 2–5) and 3 d (range 3–4) after robot-assisted uretero-ureterostomy, and 4 d (range 1–15) 
and 3 d (range 1–29) after robot-assisted ureteral reimplantation, respectively. 
3.2. Feasibility 
Four cases (2.8%) of robot-assisted pyeloplasty required conversion to open surgery, three cases for 
adverse anatomic conditions and one case because of a lost needle. All robot-assisted uretero-
ureterostomy and robot-assisted ureteral reimplantation cases were successfully completed 
robotically. None of the procedures needed additional trocars. 
3.3. Safety 
No intraoperative complications were reported. The overall postoperative complication rate was 
10.9% (n = 20; Table 3). Specifically, 8.3% (n = 12) of robot-assisted pyeloplasty cases experienced 
postoperative complications. High-grade complications (Clavien-Dindo grade III) occurred in two 
patients (1.4%) after robot-assisted pyeloplasty: one patient developed urine leakage requiring 
reintervention and the other experienced JJ stent migration. 
Table 3.  
Detailed list of postoperative complications. 
Complication Frequency, n (%) 
Robotic pyeloplasty 
 
 Anastomotic leakage (Clavien-Dindo III) 1 (0.7) 
 DJ depositioning (Clavien-Dindo III) 1 (0.7) 
 Electrolyte imbalance (Clavien-Dindo I) 2 (1.4) 
 Bleeding from a robotic port (Clavien-Dindo I) 1 (0.7) 
 Prolonged haematuria (Clavien-Dindo I) 1 (0.7) 
 Hyperpyrexia 
 
  Clavien-Dindo II (treated with antibiotics) 5 (3.4) 
  Clavien-Dindo I 1 (0.7) 
Robotic uretero-ureterostomy 
 
 Hyperpyrexia 
 
  Clavien-Dindo II (treated with antibiotics) 1 (6) 
  Clavien-Dindo I 2 (12) 
Robotic ureteral reimplantation 
 
 Laparoscopic drainage of haematoma 1 (4.8) 
 Urinary fistula 1 (4.8) 
 Hyperpyrexia 
 
  Clavien-Dindo II (treated with antibiotics) 1 (4.8) 
  Clavien-Dindo I 2 (9.5) 
Table options 
The postoperative complication rate for robot-assisted uretero-ureterostomy was 17.6% (n = 3), 
which were Clavien-Dindo grade I (n = 2) or grade II (n = 1). The postoperative complication rate 
after robot-assisted ureteral reimplantation was 23.8% (n = 5). High grade complications requiring 
surgical reintervention occurred in two cases (9.5%): one patient developed haematoma and the 
other a urinary fistula. 
3.4. Efficacy 
For robot-assisted pyeloplasty, the 2-yr recurrence-free rate was 92.5% (86.0–96.0%). The median 
pain score (visual analogue scale [VAS]) on discharge was 1 for both robot-assisted pyeloplasty 
(range 0–7) and robot-assisted laparoendoscopic single-site pyeloplasty (range 0–3). 
The 2-yr recurrence-free rate was 94.1% (65.0–99.1%) for robot-assisted uretero-ureterostomy and 
93.3% (61.3–99.0%) for robot-assisted ureteral reimplantation (Table 4). The median VAS pain 
score on discharge was 1 (range 0–3) for robot-assisted uretero-ureterostomy and 0 (range 0–2) for 
robot-assisted ureteral reimplantation. 
Table 4.  
Frequency of recurrence and 2-yr recurrence-free rate for each robotic procedure. 
 
Pyeloplasty 
Uretero-
ureterostomy 
Reimplantation 
Recurrence, n (%) 
   
 Yes 9 (6) 1 (6) 1 (5) 
 No 136 (94) 16 (94) 20 (95) 
2-yr recurrence-free rate, % 
(95% CI) 
92.5 (86.0–
96.0) 
94.1 (65.0–99.1) 93.3 (61.3–99.0) 
Table options 
4. Discussion 
It has been reported that suturing and tissue handling in a limited space can be performed more 
easily with a robot compared to conventional laparoscopy, even using other robotic system 
[8] and [9]. These factors are even more relevant in complex surgical procedures such as ureteral 
reconstructive surgery. Previous successful experiences with robot-assisted management of benign 
US have been reported, although the majority of these studies were limited by the small number of 
patients included and short follow-up time. 
Our study results provide further demonstration that robotic surgery is an effective minimally 
invasive approach for the treatment of different benign US conditions, including the upper, middle 
and distal ureter. Specifically, the proportion of patients requiring conversion to a different surgical 
procedure was 2.8% in the robot-assisted pyeloplasty group, while none of the middle and lower 
ureteral cases required conversion, confirming the feasibility of the approach. Safety was 
demonstrated by the absence of intraoperative complications. In addition, the incidence of high-
grade postoperative complications (Clavien-Dindo grade III) was low, as they occurred in just two 
patients in both the robot-assisted pyeloplasty and vesicoureteral reimplantation groups. The 
efficacy of robot-assisted surgery for benign ureteral strictures was confirmed by the high 2-yr 
recurrence-free rate, which was ≥92.5% for all the surgical procedures. To the best of our 
knowledge, the current study represents the first attempt to jointly evaluate the feasibility and 
outcomes for robot-assisted surgery for a variety of benign US conditions. The strengths of the 
current study are the relatively large sample size (given the rarity of the condition) and the fairly 
long follow-up time. 
Minnillo et al [10] demonstrated that robot-assisted pyeloplasty can be safely performed at an 
academic training institution by adoption of a robotic training program. The improvement in 
surgical results observed over a 7-yr period emphasizes that a dedicated and committed team with 
proper training can achieve long-term results similar to those for open pyeloplasty. 
In 2005 Patel et al reported the first large (n = 50) series of robot-assisted pyeloplasty cases, 
concluding that the technique, although in its infancy, offers outstanding short-term efficacy and 
minimal morbidity, as well being easier and quicker to learn [11]. Similarly, Schwentner et al [12] 
presented their 5-yr experience with 92 cases of dismembered Anderson-Hynes robotic procedures, 
reporting durable results and no late complications. Mufarrij et al [13] reported the first multi-
institutional experience, describing outcomes in 140 patients, including primary and secondary 
UPJO with or without concomitant stone extraction. Gupta et al [14] confirmed the excellent 
outcomes for this procedure in a single-institutional series of 85 patients. Etafy et al [15] attributed 
their lower success rate (81%) to the more strict criteria used for the assessment. 
To date, the largest series has been reported by Sivaraman et al. [16], who collected and analysed 
169 cases from three US institutions, and confirmed that robot-assisted pyeloplasty is a viable 
option for either primary or secondary UPJO repair with reproducible outcomes, a high success rate, 
and low incidence of complications. 
Autorino et al [17] published a systematic review and meta-analysis of robot-assisted and 
laparoscopic UPJO repair, summarizing the outcomes for surgical series that included more than 50 
patients. According to this study, the conversion rate was less than 2.3%, with a complication rate 
ranging from 1.8% to 17.9%. However, a limitation of their results is that reporting of 
complications was not standardized across different studies. The success rate was >81% at median 
follow-up ranging from 12 to 39 mo. 
While several groups have reported robot-assisted surgery outcomes for UPJO, only a few studies 
have investigated the role of this surgery in the management of mid and low ureteral pathology. The 
largest series to date is a retrospective review of 44 procedures by Hemal et al [18]. The study 
included 18 distal ureteral procedures (5 distal ureterectomies with ureteroneocystostomy; 1 
ureteroneocystostomy with psoas hitch; 2 ureteroneocystostomies with vesicovaginal fistula repair; 
8 monolateral megaureter repairs; and 1 bilateral megaureter repair), 12 proximal ureteral 
procedures (6 monolateral ureteroureterostomies, 2 bilateral ureterouretrostomies, and 4 retrocaval 
ureter repairs), ten nephroureterectomies (5 with bladder cuff resection), and four miscellaneous 
procedures. Complications included one case of sepsis and one antibiotic-induced infection. The 
average follow-up period was 13.5 mo. Operative success as defined as symptom resolution and 
100% postoperative imaging results. 
Musch et al [19] described the feasibility and short-term outcomes for different robot-assisted 
reconstructive procedures for the distal ureter. The surgical indications and operative techniques 
were as follows: seven distal ureteral resections with psoas hitch reimplantation; two extravesical 
vesicoureteral reimplantations and one end-to-end anastomosis because of a benign distal US; four 
distal ureteral resections with a psoas hitch procedure and pelvic lymphadenectomy for urothelial 
carcinoma of the ureter; one distal ureteral resection with a psoas hitch procedure and Boari flap 
because of unexpected locally recurrent prostate cancer; one extravesical reimplantation because of 
vesicoureteral reflux; one bilateral intravesical reimplantation of ectopic ureters (as part of a radical 
prostatectomy); one resection of a nonfunctioning upper kidney pole with associated megaureter 
and ureterocele and intravesical reimplantation of the lower pole ureter; and one resection of pelvic 
endometriosis and ureterolysis. There were no intraoperative complications, but there was one 
conversion to open surgery. At 3 mo after surgery, complications occurred in 12 patients (75%): ten 
(62%) were minor according to the Clavien-Dindo classification (grade I–II), while two (12%) were 
major (grades IIIb and IVa, respectively). At median follow-up of 10.2 mo, 15 patients (94%) 
remained without signs of urinary tract obstruction and 13 (81%) were asymptomatic. 
Baldie et al [20] reported on their experience and outcomes for robot-assisted mid and distal 
ureteral reconstruction (13 ureteral reimplantations and 3 ureteroureterostomies). In their study, 
there were two open conversions because of excessive scar tissue. A symptomatic bowel injury 
(Clavien grade IIIb) occurred in one case. All cases were clinically and radiographically successful 
at the last follow-up examination. 
Patil et al [21] reported the collective experience of three multinational institutions in the use of 
robotics to evaluate and treat complex distal ureteral obstruction. Twelve patients from three 
different centres underwent robotic-assisted laparoscopic ureteral reimplantation. The indications 
for ureteral reimplantation were US in ten cases and ureterovaginal fistula in two cases. All 
procedures were successfully completed robotically without open conversion. There were no 
intraoperative or postoperative complications. Postoperative intravenous urography and MAG-3 
revealed normal findings in 10 patients and mild residual hydronephrosis in two patients. After 
mean follow-up of 15.5 mo, all patients were asymptomatic. 
Phillips and Wang [22] summarized the current status for robot-assisted laparoscopic ureteral 
reimplantation and reconstruction. They performed a PubMed search using the keywords “robot” 
and “ureter”, “distal ureter”, “ureteral reimplant”, “psoas”, and “Boari”. Papers addressing proximal 
ureteral reconstruction and nephroureterectomy were excluded. A total of nine papers were 
considered as relevant, even though the largest series included fewer than 18 patients. Complication 
rates in the case reports and series reviewed were low (10%). The most common complication was 
stricture recurrence at the surgical site (5%). These strictures were managed with balloon dilation 
and chronic stent changes. There were also reports of haematuria due to bleeding at the 
anastomosis, which was controlled via transurethral fulguration. One patient developed and later 
succumbed to aspiration pneumonia. 
While the current study represents the largest series published to date on outcomes for robotic 
surgery in the treatment of benign ureteral strictures, there are several limitations that should be 
mentioned. First, the retrospective nature of the study may limit the significance of our findings. In 
addition, while the surgical techniques and follow-up protocols were standardized across the 
different institutions, the multicentre nature of our series should be taken into account when 
interpreting our results. Similarly, the heterogeneity of the study population may also be considered 
as a limitation, even though the main objective of the current study was to evaluate outcomes for 
robotic surgery for a wide range of different benign ureteral diseases. Moreover, no direct 
comparison between the outcomes for robotic surgery and those obtained with other minimally 
invasive techniques was performed. While these outcomes may not be substantially different in the 
hands of highly experienced laparoscopic surgeons, we strongly believe that the recognized 
advantages of robotic technology will help to improve accessibility for these demanding minimally 
invasive reconstructive procedures and to reduce the long learning curve associated with 
laparoscopic surgery [23]. These advantages may be even more pronounced for complex cases, 
such as secondary UPJO. Finally, the current results were obtained at high-volume centres and thus 
may not be generalisable to less experienced institutions. 
5. Conclusions 
This multi-institutional study confirms the feasibility, safety, and efficacy of robotic surgery as a 
minimally invasive alternative to open surgery for the treatment of benign ureteral strictures. 
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